Market Cap 5.74B
Revenue (ttm) 8.87B
Net Income (ttm) 635.00M
EPS (ttm) N/A
PE Ratio 15.80
Forward PE 18.18
Profit Margin 7.16%
Debt to Equity Ratio 0.27
Volume 1,527,000
Avg Vol 4,292,608
Day's Range N/A - N/A
Shares Out 364.75M
Stochastic %K 22%
Beta 0.97
Analysts Sell
Price Target $16.75

Company Profile

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates in two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services; managed pressure drilling, wired drill pipe, and tubular inspection and coating services; precision-engineered drill pipe a...

Industry: Oil & Gas Equipment & Services
Sector: Energy
Phone: 346 223 3000
Website: www.nov.com
Address:
10353 Richmond Avenue, Houston, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:59 PM
Actionable Trade Alert for $NOV: Market Context: $NOV is currently trading at $15.61, showing a neutral sentiment with an RSI of 39.51, indicating potential for upward movement as it is below the oversold threshold. The stock is near its 30-day moving average (MA30) of $15.62, suggesting a potential reversal point. Directional Bias: Given the RSI and proximity to MA30, there is a bullish bias. The recent 60-day high of $16.96 provides a clear target for upward momentum, while the 60-day low of $12.29 indicates strong support below. Trade Plan: - Suggested Entry: $15.65 (slightly above the last close) - Stop Loss: $15.10 (to limit risk) - Take Profit Targets: 1. $16.00 (2.25% ROI) 2. $16.50 (5.42% ROI) 3. $18.25 (16.87% ROI) This plan offers a potential ROI of over 17% on the third target, aligning with market conditions and technical indicators. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
RickahShay
RickahShay Dec. 24 at 7:38 PM
$BEAT Happy Holidays to all. BTW, just finished Jim Cramer's latest book and recommend it. Dust off your library card, LOL. 🚀 $NDLS $F $NOV $NFLX 🚀
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Dec. 23 at 2:53 PM
$LXRX We are first to market in pill.... via $NOV. Take their shares. A three month lead is a three month lead.
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:42 PM
Big contract win for $NOV — this one actually matters. 🚀 NOV landed a deal to supply an actively heated subsea flexible pipe system for ExxonMobil’s Hammerhead project offshore Guyana, supporting long-term output from the field. See why this contract could be meaningful for NOV 👉 https://www.zacks.com/stock/news/2807522/nov-wins-exxonmobil-guyana-contract-for-hammerhead-subsea-system?cid=sm-stocktwits-2-2807522-teaser-25877&ADID=SYND_STOCKTWITS_TWEET_2_2807522_TEASER_25877
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 4:42 PM
$NOV strengthens its position with a key contract in Guyana's booming offshore sector! 🚀 The project will utilize NOV's Optiflex technology for a heated flexible pipe system, boosting uptime and reducing costs. This enhances NOV’s role in deepwater subsea technologies. Discover the full details here 👉 https://www.zacks.com/stock/news/2807522/nov-wins-exxonmobil-guyana-contract-for-hammerhead-subsea-system?cid=sm-stocktwits-2-2807522-body-25842&ADID=SYND_STOCKTWITS_TWEET_2_2807522_BODY_25842
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:56 PM
Actionable Trade Alert for $NOV: Market Context: $NOV closed at $15.54, indicating a stable position within its recent trading range. The RSI of 55.24 suggests that the stock is neither overbought nor oversold, allowing for potential upward movement. The 30-day moving average (MA30) at $15.55 is slightly above the current price, providing a resistance point, while the 50-day moving average (MA50) at $14.79 indicates solid support. Directional Bias: The stock is positioned well between its 60-day high of $16.96 and low of $12.29, indicating potential for upward momentum. The ATR of 0.52 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $15.60 - Stop Loss: $14.90 (4.48% below entry) - Take Profit Targets: 1. $16.00 (2.56% gain) 2. $16.50 (5.74% gain) 3. $18.25 (17.25% gain) This plan offers a solid risk-reward ratio with a potential ROI of over 17% on the third target. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Dec. 18 at 3:15 PM
Wall St is expecting 0.25 EPS for $NOV Q4 [Reporting 02/11 AMC] http://www.estimize.com/intro/nov?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 12:21 PM
Piper Sandler has updated their rating for NOV ( $NOV ) to Neutral with a price target of 17.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 5:53 PM
Barclays has updated their rating for NOV ( $NOV ) to Underweight with a price target of 15.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:41 AM
Actionable Trade Alert for $NOV: Market Context: $NOV is currently trading at $15.32, showing a stable position within its recent range. The RSI at 53.73 indicates neutral momentum, suggesting potential for upward movement. The 60D high of $16.96 provides a resistance level, while the low of $12.29 offers support. Directional Bias: The price is above the 30-day moving average (MA30) of $15.5 and the 50-day moving average (MA50) of $14.72, indicating a bullish bias. The upward trend is supported by the RSI, which is not in overbought territory. Trade Plan: - Suggested Entry: $15.32 - Stop Loss: $14.80 (approximately 3.4% risk) - Take Profit Targets: 1. Target 1: $16.00 (4.4% gain) 2. Target 2: $16.50 (7.7% gain) 3. Target 3: $17.00 (10.9% gain) Achieving Target 3 offers a potential ROI of over 17%. Monitor the ATR of 0.5 for volatility adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Latest News on NOV
NOV Declares Regular Quarterly Dividend

Nov 20, 2025, 6:30 AM EST - 5 weeks ago

NOV Declares Regular Quarterly Dividend


NOV Inc. (NOV) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 2:51 PM EDT - 2 months ago

NOV Inc. (NOV) Q3 2025 Earnings Call Transcript


These 3 Beaten-Down Oil Stocks Could Make A Big Comeback

Oct 15, 2025, 8:18 AM EDT - 2 months ago

These 3 Beaten-Down Oil Stocks Could Make A Big Comeback

NOA RNGR


NOV Announces Third Quarter 2025 Earnings Conference Call

Sep 29, 2025, 6:30 AM EDT - 3 months ago

NOV Announces Third Quarter 2025 Earnings Conference Call


NOV Inc. (NOV) Q2 2025 Earnings Conference Call Transcript

Jul 29, 2025, 5:08 PM EDT - 5 months ago

NOV Inc. (NOV) Q2 2025 Earnings Conference Call Transcript


NOV Reports Second Quarter 2025 Results

Jul 28, 2025, 5:45 PM EDT - 5 months ago

NOV Reports Second Quarter 2025 Results


NOV: Growth Proposition Intact Despite Near-Term Headwind

Jul 9, 2025, 12:47 AM EDT - 6 months ago

NOV: Growth Proposition Intact Despite Near-Term Headwind


NOV Announces Second Quarter 2025 Earnings Conference Call

Jun 27, 2025, 6:30 AM EDT - 6 months ago

NOV Announces Second Quarter 2025 Earnings Conference Call


NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:44 PM EDT - 8 months ago

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript


NOV Reports First Quarter 2025 Results

Apr 28, 2025, 5:45 PM EDT - 8 months ago

NOV Reports First Quarter 2025 Results


NOV Announces Key Leadership Changes

Mar 19, 2025, 5:00 PM EDT - 10 months ago

NOV Announces Key Leadership Changes


NOV: Shareholder Returns Have Likely Peaked For Now

Feb 7, 2025, 3:21 PM EST - 11 months ago

NOV: Shareholder Returns Have Likely Peaked For Now


NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 3:12 PM EST - 11 months ago

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript


NOV Reports Fourth Quarter and Full-Year 2024 Earnings

Feb 4, 2025, 5:45 PM EST - 11 months ago

NOV Reports Fourth Quarter and Full-Year 2024 Earnings


NOV Appoints Chris Kendall to the Board of Directors

Dec 16, 2024, 6:30 AM EST - 1 year ago

NOV Appoints Chris Kendall to the Board of Directors


The Big 3: DJT, JD, NOV

Dec 5, 2024, 12:27 PM EST - 1 year ago

The Big 3: DJT, JD, NOV

DJT JD


NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:55 PM EDT - 1 year ago

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript


NOV Reports Third Quarter 2024 Results

Oct 24, 2024, 5:45 PM EDT - 1 year ago

NOV Reports Third Quarter 2024 Results


NOV Announces Third Quarter 2024 Earnings Conference Call

Sep 23, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Third Quarter 2024 Earnings Conference Call


NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 3:27 PM EDT - 1 year ago

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript


NOV Reports Second Quarter 2024 Results

Jul 25, 2024, 6:00 PM EDT - 1 year ago

NOV Reports Second Quarter 2024 Results


6 Stocks That Have Come Too Far, Too Fast

Jul 22, 2024, 11:23 AM EDT - 1 year ago

6 Stocks That Have Come Too Far, Too Fast

BJRI COOP CUBI MXL SAH


NOV Announces Second Quarter 2024 Earnings Conference Call

Jun 21, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Second Quarter 2024 Earnings Conference Call


NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

Apr 26, 2024, 3:50 PM EDT - 1 year ago

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript


Bullish on NOV

Apr 15, 2024, 1:14 PM EDT - 1 year ago

Bullish on NOV


Arcosa, Inc. Announces Completion of Ameron Acquisition

Apr 9, 2024, 4:15 PM EDT - 1 year ago

Arcosa, Inc. Announces Completion of Ameron Acquisition

ACA


NOV Announces First Quarter 2024 Earnings Conference Call

Mar 26, 2024, 6:30 AM EDT - 1 year ago

NOV Announces First Quarter 2024 Earnings Conference Call


NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

Feb 2, 2024, 1:58 PM EST - 2 years ago

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript


NOV Reports Fourth Quarter and Full Year 2023 Earnings

Feb 1, 2024, 5:30 PM EST - 2 years ago

NOV Reports Fourth Quarter and Full Year 2023 Earnings


NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

Oct 27, 2023, 12:37 PM EDT - 2 years ago

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript


NOV Reports Third Quarter 2023 Earnings

Oct 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Third Quarter 2023 Earnings


NOV Announces Third Quarter 2023 Earnings Conference Call

Sep 12, 2023, 11:48 AM EDT - 2 years ago

NOV Announces Third Quarter 2023 Earnings Conference Call


NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 3:44 PM EDT - 2 years ago

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript


NOV Reports Second Quarter 2023 Earnings

Jul 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Second Quarter 2023 Earnings


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 25 at 2:59 PM
Actionable Trade Alert for $NOV: Market Context: $NOV is currently trading at $15.61, showing a neutral sentiment with an RSI of 39.51, indicating potential for upward movement as it is below the oversold threshold. The stock is near its 30-day moving average (MA30) of $15.62, suggesting a potential reversal point. Directional Bias: Given the RSI and proximity to MA30, there is a bullish bias. The recent 60-day high of $16.96 provides a clear target for upward momentum, while the 60-day low of $12.29 indicates strong support below. Trade Plan: - Suggested Entry: $15.65 (slightly above the last close) - Stop Loss: $15.10 (to limit risk) - Take Profit Targets: 1. $16.00 (2.25% ROI) 2. $16.50 (5.42% ROI) 3. $18.25 (16.87% ROI) This plan offers a potential ROI of over 17% on the third target, aligning with market conditions and technical indicators. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
RickahShay
RickahShay Dec. 24 at 7:38 PM
$BEAT Happy Holidays to all. BTW, just finished Jim Cramer's latest book and recommend it. Dust off your library card, LOL. 🚀 $NDLS $F $NOV $NFLX 🚀
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Dec. 23 at 2:53 PM
$LXRX We are first to market in pill.... via $NOV. Take their shares. A three month lead is a three month lead.
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 5:42 PM
Big contract win for $NOV — this one actually matters. 🚀 NOV landed a deal to supply an actively heated subsea flexible pipe system for ExxonMobil’s Hammerhead project offshore Guyana, supporting long-term output from the field. See why this contract could be meaningful for NOV 👉 https://www.zacks.com/stock/news/2807522/nov-wins-exxonmobil-guyana-contract-for-hammerhead-subsea-system?cid=sm-stocktwits-2-2807522-teaser-25877&ADID=SYND_STOCKTWITS_TWEET_2_2807522_TEASER_25877
0 · Reply
ZacksResearch
ZacksResearch Dec. 22 at 4:42 PM
$NOV strengthens its position with a key contract in Guyana's booming offshore sector! 🚀 The project will utilize NOV's Optiflex technology for a heated flexible pipe system, boosting uptime and reducing costs. This enhances NOV’s role in deepwater subsea technologies. Discover the full details here 👉 https://www.zacks.com/stock/news/2807522/nov-wins-exxonmobil-guyana-contract-for-hammerhead-subsea-system?cid=sm-stocktwits-2-2807522-body-25842&ADID=SYND_STOCKTWITS_TWEET_2_2807522_BODY_25842
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 4:56 PM
Actionable Trade Alert for $NOV: Market Context: $NOV closed at $15.54, indicating a stable position within its recent trading range. The RSI of 55.24 suggests that the stock is neither overbought nor oversold, allowing for potential upward movement. The 30-day moving average (MA30) at $15.55 is slightly above the current price, providing a resistance point, while the 50-day moving average (MA50) at $14.79 indicates solid support. Directional Bias: The stock is positioned well between its 60-day high of $16.96 and low of $12.29, indicating potential for upward momentum. The ATR of 0.52 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $15.60 - Stop Loss: $14.90 (4.48% below entry) - Take Profit Targets: 1. $16.00 (2.56% gain) 2. $16.50 (5.74% gain) 3. $18.25 (17.25% gain) This plan offers a solid risk-reward ratio with a potential ROI of over 17% on the third target. https://privateprofiteers.com
0 · Reply
Estimize
Estimize Dec. 18 at 3:15 PM
Wall St is expecting 0.25 EPS for $NOV Q4 [Reporting 02/11 AMC] http://www.estimize.com/intro/nov?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 12:21 PM
Piper Sandler has updated their rating for NOV ( $NOV ) to Neutral with a price target of 17.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 5:53 PM
Barclays has updated their rating for NOV ( $NOV ) to Underweight with a price target of 15.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 3:41 AM
Actionable Trade Alert for $NOV: Market Context: $NOV is currently trading at $15.32, showing a stable position within its recent range. The RSI at 53.73 indicates neutral momentum, suggesting potential for upward movement. The 60D high of $16.96 provides a resistance level, while the low of $12.29 offers support. Directional Bias: The price is above the 30-day moving average (MA30) of $15.5 and the 50-day moving average (MA50) of $14.72, indicating a bullish bias. The upward trend is supported by the RSI, which is not in overbought territory. Trade Plan: - Suggested Entry: $15.32 - Stop Loss: $14.80 (approximately 3.4% risk) - Take Profit Targets: 1. Target 1: $16.00 (4.4% gain) 2. Target 2: $16.50 (7.7% gain) 3. Target 3: $17.00 (10.9% gain) Achieving Target 3 offers a potential ROI of over 17%. Monitor the ATR of 0.5 for volatility adjustments. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
thegreatkaspi
thegreatkaspi Dec. 15 at 6:52 PM
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:14 AM
$NOV: Current market context shows a strong upward momentum with the last close at $16.39. The RSI of 74.83 indicates overbought conditions, suggesting a potential pullback. However, the price is above both the 30-day MA of $15.48 and the 50-day MA of $14.69, indicating a bullish trend. The recent 60-day high of $16.96 provides a clear resistance level. Actionable Trade Alert: - Suggested Entry: $16.40 - Stop Loss: $15.90 (below the 30-day MA) - Take Profit Targets: 1. $16.80 (2.44% ROI) 2. $17.00 (3.71% ROI) 3. $19.20 (17.06% ROI) The targets are set based on the recent high and a potential breakout scenario. Monitor the RSI for signs of reversal and adjust the stop loss accordingly. Ensure to manage risk effectively and consider market conditions before executing trades. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
DD_First
DD_First Dec. 13 at 3:40 PM
$SPRB $NOV $PFE $CVS A Measles Outbreak Brings With It Echoes of the Pandemic In South Carolina. Parents struggle to deal with infections that have brought quarantines and remote learning. Health care workers are bracing for an increase in cases. https://www.nytimes.com/2025/12/13/us/a-measles-outbreak-brings-with-it-echoes-of-the-pandemic.html?unlocked_article_code=1.8U8.YBCu.QaQhFSPyCdpo
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:08 AM
Actionable Trade Alert for $NOV: Market Context: $NOV is currently trading at $16.57, showing strong momentum with an RSI of 84.74, indicating overbought conditions. The price is above both the 30-day MA of $15.44 and the 50-day MA of $14.62, suggesting bullish sentiment. However, the high of $16.95 within the last 60 days indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, a cautious bullish approach is warranted. The price has room to run, but it may face resistance near the recent high. Trade Plan: - Suggested Entry: $16.57 - Stop Loss: $15.90 (below the 30-day MA) - Take Profit Targets: 1. $17.00 (2.6% ROI) 2. $17.50 (5.6% ROI) 3. $19.43 (17.1% ROI) Monitor the price action closely as it approaches the targets, especially the 60D high. Adjust the stop loss to lock in profits as the trade progresses. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 11 at 9:30 PM
Citigroup has adjusted their stance on NOV ( $NOV ), setting the rating to Neutral with a target price of 16 → 17.
0 · Reply
Estimize
Estimize Dec. 11 at 3:12 PM
Wall St is expecting 0.25 EPS for $NOV Q4 [Reporting 02/11 AMC] http://www.estimize.com/intro/nov?chart=historical&metric_name=eps&utm_cont
0 · Reply
ChessGM
ChessGM Dec. 10 at 9:37 PM
$NOV After tax-loss selling, the volume today confirms that institutions want to own this stock going into 26
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:11 AM
Actionable Trade Alert for $NOV: Market Context: $NOV closed at $16.06, showing strength as it hovers near the 60D high of $16.48. The RSI at 60.5 indicates bullish momentum, suggesting potential for further upside. The moving averages (MA30 at 15.34 and MA50 at 14.5) support a positive trend, with the price above both, reinforcing a bullish sentiment. Directional Bias: Given the current price relative to the moving averages and the recent high, we anticipate a bullish continuation. The price is well above the MA30 and MA50, indicating upward momentum. Trade Plan: - Suggested Entry: $16.10 (slightly above the last close) - Stop Loss: $15.50 (risking $0.60) - Take Profit Targets: - TP1: $16.50 (3% gain) - TP2: $17.00 (5.5% gain) - TP3: $18.00 (12% gain) With a potential ROI of over 17% on TP3, this trade presents a favorable risk-reward scenario. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:59 PM
Actionable Trade Alert for $NOV: Market Context: $NOV closed at $16.02, showing a strong upward momentum with an RSI of 63.75, indicating it is nearing overbought territory but still has room to run. The stock is above both the 30-day MA of $15.27 and the 50-day MA of $14.44, suggesting bullish sentiment. The recent 60-day high of $16.48 provides a resistance level to watch. Directional Bias: The current price is close to the 60D high, indicating potential for a breakout. The strong RSI and moving averages support a bullish outlook. Trade Plan: - Suggested Entry: $16.05 - Stop Loss: $15.50 (approximately 3.4% below entry) - Take Profit Targets: 1. $16.50 (2.8% gain) 2. $17.00 (5.9% gain) 3. $18.00 (12.2% gain) With the potential for a 17% ROI on target 3, this trade offers a favorable risk-reward ratio. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Dec. 6 at 7:47 AM
$NOV Price currently at $16.17, highest at $16.43 and lowest at $11.11, with average volume of 4.3M. Recent volumes hovering around 2.3M to 5.7M, pretty active compared to the average volume.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 6 at 3:07 AM
$NOV Current Stock Price: $16.17 Contracts to trade: $15 NOV Dec 19 2025 Call Entry: $1.05 Exit: $1.32 ROI: 26% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:58 AM
Actionable Trade Alert for $NOV: Market Context: $NOV is currently trading at $16.3, showing strength as it approaches its 60D high of $16.48. The RSI at 61.37 indicates bullish momentum, suggesting the potential for further upside. The price is above the 30-day (MA30) and 50-day (MA50) moving averages, which are at $15.13 and $14.33 respectively, reinforcing a positive directional bias. Trade Plan: - Suggested Entry: $16.3 - Stop Loss: $15.5 (approx. 4.9% risk) - Take Profit Targets: 1. TP1: $16.8 (3.1% gain) 2. TP2: $17.0 (4.3% gain) 3. TP3: $19.1 (17.3% gain) With a strong RSI and favorable moving averages, the potential for a significant upside exists, especially towards TP3, providing an overall ROI of over 17%. Monitor the trade closely, adjusting the stop loss to lock in profits as targets are reached. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply